Odenholt-Tornquistl, LowdinE., CarsO.Postantibiotic sub-MIC effects of vancomycin, roxithromycin sparfloxin and amikacinAntimicrob Chemother1992; 36: 1852–8.
5.
CalandraT., ZinnerS., ViscoliC.Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia.Ann Intern Med1993; 119: 584–93.
6.
VasS.I.Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis.Perit Dial Int1993; 13(Suppl 2): S355–6.
7.
ChongT.K., PirainoB., BernardiniJ.Vestibular toxicity due to gentamicin in peritoneal dialysis patients.Perit Dial Int1991; 11: 152–5.
FreimanJ.P., GrahamD.J., ReedT.G., McGoodwinE.B.Chemical peritonitis following the intraperitoneal administration of vancomycin.Perit Dial Int1992; 12: 57–60.
KeaneW.F., EverettE.D., GolperT.A.Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Thead hoc advisory committee on peritonitis management.PeritDiallnt1993; 13: 14–28.
12.
WilliamsP., KhannaR., SimpsonH., VasS.I.Tobramycin blood levels of CAPD patients during peritonitis.Perit Dial Bull1982; 2: 48.
13.
ManuelM.A., PatonT.W., CornishW.R.Drugs and peritoneal dialysis.Perit Dial Bull1983; 3: 117–25.
14.
SeweiiD.L., GolperT.A.Stability of antimicrobial agents in peritoneal dialysate.Antimicrob Agents Chemother1982; 21: 528–9.
15.
SewellD.L., GolperT.A., BrownS.D., NelsonE., KnowerM., KimbroughR.C.Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin.Am J Kidney Dis1983; 3: 209–12.
16.
BunkeC.M., AronoffG.R., LuftC.Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis.Am J Kidney Dis1983; 3: 114–17.
PirainoB., BernardiniJ., JohnstonJ., SorkinM.Chemical peritonitis due to intraperitoneal vancomycin (vancoled).Perit Dial Bull1987; 7: 156–9.
19.
GokalR., VasS.I.Risk of tobramycin use in CAPD patients with peritonitis.PeritDialBull1982; 2: 139–41.
20.
SilvaJ., FeketyR.Clostridia and antimicrobial entocolitis.Am Rev Med1981; 32: 327–33.
21.
Antibiotic lavage for peritonitis (Editorial).Br Med J1979; 691–2.
22.
DuweA., VasS.I., WeatherheadJ.W.Effect of composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro.Infect Immun1981; 33: 130–5.
DigenisG.E., KhannaR., PierratosA., VasS.Morbidity and mortality after treatment of peritonitis with prolonged exchanges and intraperitoneal antibiotics.Perit Dial Bull1982; 2: 45–6.
26.
CantaluppiA., ScalamognaA., GuerraL., GrazianiG., PonticelliC.Treatment of peritonitis in patients on CAPD.Perit Dial Bull1982; 2: 142.
27.
WilliamsP., KhannaR., VasS., LayneS., PantalonyD., OreopoulosD.G.Treatment of peritonitis in patients on CAPD: to lavage or not.Perit Dial Bull1980; 1: 14–17.
28.
DeGrocF., RottembourgJ., J acqD., JaslierV., N'GuyenJ., LegrainM.Les peritonites au cours de la dialyse peritoneal continue ambulatoire. Traitment par lavage ou non? Etude prospective.Nephrologie1983; 4: 24–7.
29.
De TremontJ.F., KhissiH., ThomasD.Traitment des peritonites ou dialyse peritoneal. Comparison entre lavage continue avec machine et lavage intermittent par quatre sac/jour de DPCA.Pathol Biol1983; 31: 544–7.
30.
O'LearyJ.P., MalikF.S., DonahoeR.R., JohnstonA.D.The effects of a minidose of heparin on peritonitis in rats.Surg Gynecol Obstet1979; 148: 571–5.
31.
PirainoB., BernardiniJ., SorkinM.The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections and catheter loss in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1986; 8: 436–40.
32.
VI. Catheter-related factors and peritonitis risk in CAPD patients.USRDS 1992 Annual Report.Am J Kidney Dis1993; 20(Suppl 2): 48–54.
33.
ScalamognaA., CastelnovoC., DeVecchiA., PonticelliC.Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1992; 18: 674–7.
ProwantB.F., WaradyB.A., NolphK.D.Peritoneal dialysis exit-site care: results of an international survey.Perit Dial Int1993; 13: 149–54.
36.
HelfrichG.B., WinchesterJ.F.Shaving of external cuff of peritoneal catheter.Perit Dial Bull1982; 2: 183.
37.
PirainoB., BernardiniJ., PeitzmanA., SorkinM.Failure of peritoneal cuff shaving to eradicate infection.Perit Dial Bull1987; 7: 179–82.
38.
NicholsW.K., NolphK.D.A technique for managing exitsite and cuff infection in Tenckhoff catheters.Perit Dial Bull1983; 3(Suppl): S4–5.
39.
VasS.I.Indications for removal of peritoneal catheter.Perit Dial Bull1981; 1: 145–6.
40.
PatersonA.D., BishopM.C., MorganA.G., BurdenR.P.Removal and replacement of Tenckhoff catheter at a single operation: successful treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis.Lancet1986; ii: 1245–7.
41.
EreminJ., MarshallV.C.The place of prophylactic antibiotics in peritoneal dialysis.Aust Ann Med1969; 18: 264–6.
42.
SharmaB.K., SmithE.C., RodriguezH., PillayU.K.G., GandhiV.C., DuneaG.Trial of oral neomycin during peritoneal dialysis.Am J Med Sci1971; 262: 175–8.
43.
AxelrodJ., MeyersB.R., HirschmanS.Z., SteinR.Prophylaxis with cephalothin in peritoneal dialysis.Arch Intern Med1973; 132: 368–71.
44.
LowD.E., VasS.I., OreopoulosD.G.Randomized clinical trial of prophylactic cephalexin in CAPD.Lancet1980; 2: 753–4.
45.
ChurchillD.N., OreopoulosD.G., TaylorD.W., VasS.I., ManuelM.A., WuG.Peritonitis in CAPD patients-a randomized clinical trial of trimethoprim-sulfamethoxazole prophylaxis. Abstracts of the 20th Annual Meeting of the American Society of Nephrology, 1987: 97A.